date,title,source
Oct-25-18,"Concert Pharmaceuticals to Report Third Quarter 2018 Financial Results on November 1, 2018",Business Wire
Nov-01-18,Edited Transcript of CNCE earnings conference call or presentation 1-Nov-18 12:30pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Concert: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Concert Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Company Update,Business Wire
Nov-05-18,"Concert Pharmaceuticals Presents Preclinical Data on CTP-692, a Novel Drug Candidate for Schizophrenia, Supporting Potential to Improve Safety Profile of D-Serine",Business Wire
Nov-05-18,Edited Transcript of CNCE earnings conference call or presentation 1-Nov-18 12:30pm GMT,Thomson Reuters StreetEvents
Nov-06-18,Edited Transcript of CNCE earnings conference call or presentation 1-Nov-18 12:30pm GMT,Thomson Reuters StreetEvents
Nov-07-18,Concert Pharmaceuticals to Participate at Upcoming Investor Conferences,Business Wire
Nov-12-18,"Report: Exploring Fundamental Drivers Behind Sterling Construction, Tredegar, j2 Global, Medical Transcription Billing, Concert Pharmaceuticals, and Senseonics  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-12-18,Concert Pharmaceuticals Reports Positive CTP-543 Results from Interim Analysis of Phase 2a Trial in Patients with Alopecia Areata,Business Wire
